Can we, should we, eradicate the meningococcus?

被引:11
|
作者
Maiden, Martin C. J. [1 ]
Frosch, Matthias [2 ]
机构
[1] Univ Oxford, Dept Zool, Oxford OX1 3PS, England
[2] Univ Wurzburg, Inst Fuer Hyg & Mikrobiol, D-97080 Wurzburg, Germany
基金
英国惠康基金;
关键词
Neisseria meningitidis; Vaccines; Epidemiology; Population biology; NEISSERIA-MENINGITIDIS; CARRIED MENINGOCOCCI; CONJUGATE VACCINE; SEROGROUP; DISEASE; IMMUNITY; IMMUNOGENICITY; DIVERSITY; EVOLUTION; VIRULENCE;
D O I
10.1016/j.vaccine.2011.12.068
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The eradication of infectious agents is an attractive means of disease control that, to date, has been achieved for only one human pathogen, the smallpox virus. The introduction of vaccines against Neisseria meningitidis into immunisation schedules, and particularly the conjugate polysaccharide vaccines which can interrupt transmission, raises the question of whether disease caused by this obligate human bacterium can be controlled, eliminated, or even eradicated. The limited number of meningococcal serogroups, lack of an animal reservoir, and importance of meningococcal disease are considerations in favour of eradication; however, the commensal nature of most infections, the high diversity of meningococcal populations, and the lack of comprehensive vaccines are all factors that suggest that this is not feasible. Indeed, any such attempt might be harmful by perturbing the human microbiome and its interaction with the immune system. On balance, the control and possible elimination of disease caused by particular disease-associated meningococcal genotypes is a more achievable and worthwhile goal. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:B52 / B56
页数:5
相关论文
共 50 条
  • [1] Can we eradicate viral pathogens?
    Alizon, Samuel
    Turner, Paul E.
    JOURNAL OF EVOLUTIONARY BIOLOGY, 2021, 34 (12) : 1851 - 1854
  • [2] How Can We Eradicate Pertussis
    Cherry, James D.
    HOT TOPICS IN INFECTION AND IMMUNITY IN CHILDREN V, 2009, 634 : 41 - 51
  • [3] Can we eradicate trachoma? A survey of stakeholders
    Oldenburg, Catherine E.
    Aragie, Solomon
    Amza, Abdou
    Solomon, Anthony W.
    Brogdon, Jessica
    Arnold, Benjamin F.
    Keenan, Jeremy D.
    Lietman, Thomas M.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (08) : 1059 - 1062
  • [4] Cities and diversity - Should we want it? Can we plan for it?
    Fainstein, SS
    URBAN AFFAIRS REVIEW, 2005, 41 (01) : 3 - 19
  • [5] Liver Allocation: Can We Ever Get It Right and Should We Ever Get It Right?
    Neuberger, James
    Mulligan, David
    HEPATOLOGY, 2015, 61 (01) : 28 - 31
  • [6] Hepatitis C: Could we eradicate this virus?
    Alvarez, Fernando
    Cuarterolo, Miriam L.
    Ciocca, Mirta
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2021, 119 (03): : 208 - 212
  • [7] Can we defeat meningococcal disease in low and middle income countries?
    Greenwood, Brian
    Chiarot, Emiliano
    MacLennan, Calman A.
    O'Ryan, Miguel
    VACCINE, 2012, 30 : B63 - B66
  • [8] Red meat and colon cancer: Should we become vegetarians, or can we make meat safer?
    Corpet, Denis E.
    MEAT SCIENCE, 2011, 89 (03) : 310 - 316
  • [9] Pneumococcal Vaccination: Should We Kill the Enemy or Just Disarm It?
    Lujan, Manel
    Gallego, Miguel
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (02) : 148 - 149